Direct injection of functional single-domain antibodies from E. coli into human cells

45Citations
Citations of this article
116Readers
Mendeley users who have this article in their library.

Abstract

Intracellular proteins have a great potential as targets for therapeutic antibodies (Abs) but the plasma membrane prevents access to these antigens. Ab fragments and IgGs are selected and engineered in E. coli and this microorganism may be also an ideal vector for their intracellular delivery. In this work we demonstrate that single-domain Ab (sdAbs) can be engineered to be injected into human cells by E. coli bacteria carrying molecular syringes assembled by a type III protein secretion system (T3SS). The injected sdAbs accumulate in the cytoplasm of HeLa cells at levels ca. 105-106 molecules per cell and their functionality is shown by the isolation of sdAb-antigen complexes. Injection of sdAbs does not require bacterial invasion or the transfer of genetic material. These results are proof-of-principle for the capacity of E. coli bacteria to directly deliver intracellular sdAbs (intrabodies) into human cells for analytical and therapeutic purposes. © 2010 Blanco-Toribio et al.

Cite

CITATION STYLE

APA

Blanco-Toribio, A., Muyldermans, S., Frankel, G., & Fernández, L. Á. (2010). Direct injection of functional single-domain antibodies from E. coli into human cells. PLoS ONE, 5(12). https://doi.org/10.1371/journal.pone.0015227

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free